Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Current Hematology Reports
|
August 7, 2003
Gene therapy for fanconi anemia
James M Croop
Journal of Pediatric Hematology/Oncology
|
August 13, 2005
Germline p53 mutation presenting as synchronous tumors
Mary Ellen Cavalier, Mary M Davis, James M Croop
Seminars in Oncology Nursing
|
June 21, 2021
Parents' Insights into Pediatric Oncology Phase I Clinical Trials: Experiences from Their Child's Participation
Stacey Crane, James M Croop, Jill Lee, et al.
Pediatric Blood & Cancer
|
May 29, 2019
Evidence for BCR/ABL1-positive T-cell acute lymphoblastic leukemia arising in an early lymphoid progenitor cell
Susanne Ragg, Barbara K Zehentner, Michael R Loken, et al.
American Journal of Hematology
|
February 24, 2005
Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura
Manjusha Kumar, Terry A Vik, Cynthia S Johnson, et al.
European Journal of Clinical Pharmacology
|
October 3, 2009
Population pharmacokinetics of intravenous ondansetron in oncology and surgical patients aged 1-48 months
John T Mondick, Brendan M Johnson, Lynda J Haberer, et al.
Frontiers in Pediatrics
|
June 9, 2023
A phase 1, first-in-child, multicenter study to evaluate the safety and efficacy of the oncolytic herpes virus talimogene laherparepvec in pediatric patients with advanced solid tumors
Lucas Moreno, Pierre Teira, James M Croop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2005
Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: a Children's Oncology Group Study
Najat C Daw, Wayne L Furman, Clinton F Stewart, et al.
Pediatric Blood & Cancer
|
May 2, 2025
A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors
Filemon S Dela Cruz, Elizabeth Fox, Steven G DuBois, et al.
Blood
|
October 7, 2022
PRL2 phosphatase enhances oncogenic FLT3 signaling via dephosphorylation of the E3 ubiquitin ligase CBL at tyrosine 371
Hongxia Chen, Yunpeng Bai, Michihiro Kobayashi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Current Hematology Reports
|
August 7, 2003
Gene therapy for fanconi anemia
James M Croop
Journal of Pediatric Hematology/Oncology
|
August 13, 2005
Germline p53 mutation presenting as synchronous tumors
Mary Ellen Cavalier, Mary M Davis, James M Croop
Seminars in Oncology Nursing
|
June 21, 2021
Parents' Insights into Pediatric Oncology Phase I Clinical Trials: Experiences from Their Child's Participation
Stacey Crane, James M Croop, Jill Lee, et al.
Pediatric Blood & Cancer
|
May 29, 2019
Evidence for BCR/ABL1-positive T-cell acute lymphoblastic leukemia arising in an early lymphoid progenitor cell
Susanne Ragg, Barbara K Zehentner, Michael R Loken, et al.
American Journal of Hematology
|
February 24, 2005
Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura
Manjusha Kumar, Terry A Vik, Cynthia S Johnson, et al.
European Journal of Clinical Pharmacology
|
October 3, 2009
Population pharmacokinetics of intravenous ondansetron in oncology and surgical patients aged 1-48 months
John T Mondick, Brendan M Johnson, Lynda J Haberer, et al.
Frontiers in Pediatrics
|
June 9, 2023
A phase 1, first-in-child, multicenter study to evaluate the safety and efficacy of the oncolytic herpes virus talimogene laherparepvec in pediatric patients with advanced solid tumors
Lucas Moreno, Pierre Teira, James M Croop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2005
Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: a Children's Oncology Group Study
Najat C Daw, Wayne L Furman, Clinton F Stewart, et al.
Pediatric Blood & Cancer
|
May 2, 2025
A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors
Filemon S Dela Cruz, Elizabeth Fox, Steven G DuBois, et al.
Blood
|
October 7, 2022
PRL2 phosphatase enhances oncogenic FLT3 signaling via dephosphorylation of the E3 ubiquitin ligase CBL at tyrosine 371
Hongxia Chen, Yunpeng Bai, Michihiro Kobayashi, et al.
Page
of 2